Horizon Pharma (HZNP) Tops Q4 EPS by 13c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Horizon Pharma plc Announces Fourth-Quarter and Full-Year 2016 Financial Results and Provides Full-Year 2017 Net Sales and Adjusted EBITDA Guidance
February 27, 2017 7:01 AM EST-- Fourth-Quarter 2016 Net Sales of $310.3 Million; Up 27 Percent ---- Fourth-Quarter 2016 Net Loss of $130.5 Million(1); Adjusted EBITDA of $136.4 Million --
-- Fourth-Quarter 2016 Operating Cash Flow of $139.2 Million;Fourth-Quarter 2016 Non-GAAP Operating Cash Flow of $193.1 Million --
-- Full-Year 2016 Net Sales of $981.1 Million(2);Full-Year 2016 Non-GAAP Adjusted Net Sales of $1,046.1 Million(2) --
-- Full-Year 2016 Net Loss of $166.8 Million(1); Adjusted EBITDA of $470.7 Million
-- Full-Year 2016 Operating Cash Flow of $369.5 Million;Full-Year 2016 Non-GAAP Operating Cash Flow of $452.9 Million;Year-End 2016 Cash Balance of $509.1 Million --
--... More
